Reuters logo
BRIEF-Synergy Pharmaceuticals provides update on phase 3 data results for Trulance
February 7, 2017 / 5:22 PM / 10 months ago

BRIEF-Synergy Pharmaceuticals provides update on phase 3 data results for Trulance

Feb 7 (Reuters) - Synergy Pharmaceuticals Inc:

* Pivotal phase 3 data results for Trulance(Tm) (plecanatide) in the treatment of chronic idiopathic constipation (CIC) published in American Journal Of Gastroenterology

* Says Trulance will be available in U.S. this quarter

* Plans to file new drug application supplement with clinical data this quarter with an expected 10-month review period from submission Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below